Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis.

Systematic review of schizophrenia

Barry, S.J.E.
Gaughan, T.M.
Hunter, R.

January 2012

INTRODUCTION: The prevalence of schizophrenia is thought to be about one in 100; about 75% ...

Negative symptoms in schizophrenia:Reconsidering evidence and focus in clinical trials

van der Meer, Lisette
Kaiser, Stefan
Castelein, Stynke

July 2021

Negative symptoms of schizophrenia have been documented in the literature for over a century. Nevert...

Negative symptoms in schizophrenia:Reconsidering evidence and focus in clinical trials

van der Meer, Lisette
Kaiser, Stefan
Castelein, Stynke

July 2021

Negative symptoms of schizophrenia have been documented in the literature for over a century. Nevert...

Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis.

Krause, M

Data of the following publication: Krause, Marc; Zhu, Yikang; Huhn, Maximilian; Schneider-Thoma, Joh...

Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials

Fusar Poli, Paolo
Papanastasiou, Evangelos
Stahl, Daniel
Carpenter, William
Shergill, Sukhwinder
Mcguire, Philip
ROCCHETTI, MATTEO

January 2015

OBJECTIVES: Existing treatments for schizophrenia can improve positive symptoms, but it is unclear i...

Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis.

Krause, Marc
Zhu, Yikang
Huhn, Maximilian
Schneider-Thoma, Johannes
Bighelli, Irene
Nikolakopoulou, Adriani
Leucht, Stefan

October 2018

BACKGROUND Negative symptoms are the core of schizophrenia, but whether antipsychotics are effica...

Efficacy, acceptability, and tolerability of antipsychotics in children and adolescents with schizophrenia: A network meta-analysis

Krause, M

Data of the following publication: Krause, Marc; Zhu, Yikang; Huhn, Maximilian; Schneider-Thoma, Joh...

Prodopaminergic Drugs for Treating the Negative Symptoms of Schizophrenia: Systematic Review and Meta-analysis of Randomized Controlled Trials

Sabe, Michel
Kirschner, Matthias
Kaiser, Stefan

January 2019

BACKGROUND The negative symptoms of schizophrenia pose a heavy burden on patients and relatives a...

Prodopaminergic Drugs for Treating the Negative Symptoms of Schizophrenia: Systematic Review and Meta-analysis of Randomized Controlled Trials

Sabe, Michel
Kirschner, Matthias
Kaiser, Stefan

January 2019

BACKGROUND The negative symptoms of schizophrenia pose a heavy burden on patients and relatives a...

Prodopaminergic Drugs for Treating the Negative Symptoms of Schizophrenia: Systematic Review and Meta-analysis of Randomized Controlled Trials

Sabe, Michel
Kirschner, Matthias
Kaiser, Stefan

January 2019

BACKGROUND The negative symptoms of schizophrenia pose a heavy burden on patients and relatives a...

Pharmacological treatment of negative symptoms in schizophrenia.

Moller HJ
Czobor, Pál

November 2015

Effective treatment of negative symptoms is one of the most important unmet needs in schizophrenic d...

Data_Sheet_1_Are Patients With Schizophrenia Spectrum Disorders More Prone to Manifest Nocebo-Like-Effects? A Meta-Analysis of Adverse Events in Placebo Groups of Double-Blind Antipsychotic Trials.PDF

Sara Palermo (5773856)
Fabio Giovannelli (382699)
Massimo Bartoli (6710033)
Martina Amanzio (142645)

May 2019

Background: Antipsychotic clinical trials use to present adverse events (AEs) for the drug under eva...

Antipsychotics for negative and positive symptoms of schizophrenia: dose-response meta-analysis of randomized controlled acute phase trials

Sabe, Michel
Zhao, Nan
Crippa, Alessio
Kaiser, Stefan

January 2021

Determining the optimal antipsychotic target dose in acute phase treatment is of high clinical relev...

The effectiveness and safety of cariprazine in schizophrenia patients with negative symptoms and insufficient effectiveness of previous antipsychotic therapy : An observational study

Rancans, Elmars
Dombi, Zsfia Borbila
Mátrai, Péter
Barabassy, Agota
Sebe, Barbara
Skrivele, Iveta
Németh, György

January 2021

Systematic review of schizophrenia

Barry, S.J.E.
Gaughan, T.M.
Hunter, R.

January 2012

INTRODUCTION: The prevalence of schizophrenia is thought to be about one in 100; about 75% ...

Systematic review of schizophrenia

Barry, S.J.E.
Gaughan, T.M.
Hunter, R.

January 2012

INTRODUCTION: The prevalence of schizophrenia is thought to be about one in 100; about 75% ...

Negative symptoms in schizophrenia:Reconsidering evidence and focus in clinical trials

van der Meer, Lisette
Kaiser, Stefan
Castelein, Stynke

July 2021

Negative symptoms of schizophrenia have been documented in the literature for over a century. Nevert...

Negative symptoms in schizophrenia:Reconsidering evidence and focus in clinical trials

van der Meer, Lisette
Kaiser, Stefan
Castelein, Stynke

July 2021

Negative symptoms of schizophrenia have been documented in the literature for over a century. Nevert...

Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis.

Krause, M

Data of the following publication: Krause, Marc; Zhu, Yikang; Huhn, Maximilian; Schneider-Thoma, Joh...

Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials

Fusar Poli, Paolo
Papanastasiou, Evangelos
Stahl, Daniel
Carpenter, William
Shergill, Sukhwinder
Mcguire, Philip
ROCCHETTI, MATTEO

January 2015

OBJECTIVES: Existing treatments for schizophrenia can improve positive symptoms, but it is unclear i...

Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis.

Krause, Marc
Zhu, Yikang
Huhn, Maximilian
Schneider-Thoma, Johannes
Bighelli, Irene
Nikolakopoulou, Adriani
Leucht, Stefan

October 2018

BACKGROUND Negative symptoms are the core of schizophrenia, but whether antipsychotics are effica...

Efficacy, acceptability, and tolerability of antipsychotics in children and adolescents with schizophrenia: A network meta-analysis

Krause, M

Data of the following publication: Krause, Marc; Zhu, Yikang; Huhn, Maximilian; Schneider-Thoma, Joh...

Prodopaminergic Drugs for Treating the Negative Symptoms of Schizophrenia: Systematic Review and Meta-analysis of Randomized Controlled Trials

Sabe, Michel
Kirschner, Matthias
Kaiser, Stefan

January 2019

BACKGROUND The negative symptoms of schizophrenia pose a heavy burden on patients and relatives a...

Prodopaminergic Drugs for Treating the Negative Symptoms of Schizophrenia: Systematic Review and Meta-analysis of Randomized Controlled Trials

Sabe, Michel
Kirschner, Matthias
Kaiser, Stefan

January 2019

BACKGROUND The negative symptoms of schizophrenia pose a heavy burden on patients and relatives a...

Prodopaminergic Drugs for Treating the Negative Symptoms of Schizophrenia: Systematic Review and Meta-analysis of Randomized Controlled Trials

Sabe, Michel
Kirschner, Matthias
Kaiser, Stefan

January 2019

BACKGROUND The negative symptoms of schizophrenia pose a heavy burden on patients and relatives a...

Pharmacological treatment of negative symptoms in schizophrenia.

Moller HJ
Czobor, Pál

November 2015

Effective treatment of negative symptoms is one of the most important unmet needs in schizophrenic d...

Data_Sheet_1_Are Patients With Schizophrenia Spectrum Disorders More Prone to Manifest Nocebo-Like-Effects? A Meta-Analysis of Adverse Events in Placebo Groups of Double-Blind Antipsychotic Trials.PDF

Sara Palermo (5773856)
Fabio Giovannelli (382699)
Massimo Bartoli (6710033)
Martina Amanzio (142645)

May 2019

Background: Antipsychotic clinical trials use to present adverse events (AEs) for the drug under eva...

Antipsychotics for negative and positive symptoms of schizophrenia: dose-response meta-analysis of randomized controlled acute phase trials

Sabe, Michel
Zhao, Nan
Crippa, Alessio
Kaiser, Stefan

January 2021

Determining the optimal antipsychotic target dose in acute phase treatment is of high clinical relev...

The effectiveness and safety of cariprazine in schizophrenia patients with negative symptoms and insufficient effectiveness of previous antipsychotic therapy : An observational study

Rancans, Elmars
Dombi, Zsfia Borbila
Mátrai, Péter
Barabassy, Agota
Sebe, Barbara
Skrivele, Iveta
Németh, György

January 2021

Systematic review of schizophrenia

Barry, S.J.E.
Gaughan, T.M.
Hunter, R.

January 2012

INTRODUCTION: The prevalence of schizophrenia is thought to be about one in 100; about 75% ...

Systematic review of schizophrenia

Barry, S.J.E.
Gaughan, T.M.
Hunter, R.

January 2012

INTRODUCTION: The prevalence of schizophrenia is thought to be about one in 100; about 75% ...

Negative symptoms in schizophrenia:Reconsidering evidence and focus in clinical trials

van der Meer, Lisette
Kaiser, Stefan
Castelein, Stynke

July 2021

Negative symptoms of schizophrenia have been documented in the literature for over a century. Nevert...

Negative symptoms in schizophrenia:Reconsidering evidence and focus in clinical trials

van der Meer, Lisette
Kaiser, Stefan
Castelein, Stynke

July 2021

Negative symptoms of schizophrenia have been documented in the literature for over a century. Nevert...

Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis.

Abstract

Extracted data

Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis.

Abstract

Extracted data

Related items

Related items